Rats given daily doses of pravastatin - sold as Pravachol
- had to recognise a previously seen object and find a food reward.
He said in other prevention studies, the five-year NNT values for people with high cholesterol ranged from 44, for those taking the statin drug pravastatin or Pravachol
, made by Bristol-Myers Squibb Co.
The statin drugs Lescol (fluvastatin) Pravachol
(pravastatin), and Crestor (rosuvastatin) are unaffected by amiodarone.
The plant, operating for 36 years, produces Pravachol
for heart disease and Glucophage for diabetes.
In addition, if combined with Sustiva, the following drugs may require a change in the dose of either Sustiva or the other medicine: Ritadin (ritampin); Sporanox (itraconazole); Nizoral (ketoconazole); calcium-channel blockers (for example, Cardizem, Tiazac, and others); and the cholesterol-lowering medications Lipitor (atorvastatin), Pravachol
(pravastatin), and Zocor (simvastatin).
The makers of a cholesterol-lowering statin drug called Pravachol
claimed that it reduced strokes in patients by 19 percent.
Statins like Lipitor and Pravachol
lower both LDL ("bad") cholesterol and CRP, a measure of inflammation.
For all other statins (including Lipitor, Zocor, Lescol, Pravachol
and Mevacor), there have been 27 cases of acute renal failure or renal insufficiency reported from January 1, 2001, through September 30, 2004, out of 316 million prescriptions filled-a rate of .
For example, Pravachol
was the preferred statin on Michigan's list until the Medicaid program switched to Lipitor, Dr.
The Food and Drug Administration's new commissioner highlighted the order to Pravachol
maker Bristol-Myers Squibb Co.
There is also evidence for the cholesterol-lowering drugs called statins (Lipitor, Lescol, Mevacor, Pravachol
and Zocor) that, when started in middle to later middle-age years, they reduce the risk of dementia, type 2 diabetes and osteoporosis.
Moody's said sales of Sankyo's cholesterol reducer, Mevalotin, sold as Pravachol
in the United States, are likely to decline due to price-cutting and stronger competition from new drugs.